181 related articles for article (PubMed ID: 37358620)
1. Next-generation PET/CT imaging in meningioma-first clinical experiences using the novel SSTR-targeting peptide [
Unterrainer M; Kunte SC; Unterrainer LM; Holzgreve A; Delker A; Lindner S; Beyer L; Brendel M; Kunz WG; Winkelmann M; Cyran CC; Ricke J; Jurkschat K; Wängler C; Wängler B; Schirrmacher R; Belka C; Niyazi M; Tonn JC; Bartenstein P; Albert NL
Eur J Nucl Med Mol Imaging; 2023 Sep; 50(11):3390-3399. PubMed ID: 37358620
[TBL] [Abstract][Full Text] [Related]
2. PET Imaging of Meningioma Using the Novel SSTR-Targeting Peptide 18F-SiTATE.
Unterrainer M; Lindner S; Beyer L; Gildehaus FJ; Todica A; Mittlmeier LM; Jurkschat K; Wängler C; Wängler B; Schirrmacher R; Tonn JC; Albert NL; Bartenstein P; Ilhan H
Clin Nucl Med; 2021 Aug; 46(8):667-668. PubMed ID: 33782306
[TBL] [Abstract][Full Text] [Related]
3. Validation of the standardization framework SSTR-RADS 1.0 for neuroendocrine tumors using the novel SSTR‑targeting peptide [
Ebner R; Lohse A; Fabritius MP; Rübenthaler J; Wängler C; Wängler B; Schirrmacher R; Völter F; Schmid HP; Unterrainer LM; Öcal O; Hinterberger A; Spitzweg C; Auernhammer CJ; Geyer T; Ricke J; Bartenstein P; Holzgreve A; Grawe F
Eur Radiol; 2024 May; ():. PubMed ID: 38769164
[TBL] [Abstract][Full Text] [Related]
4. Semi-automated segmentation methods of SSTR PET for dosimetry prediction in refractory meningioma patients treated by SSTR-targeted peptide receptor radionuclide therapy.
Boursier C; Zaragori T; Bros M; Bordonne M; Melki S; Taillandier L; Blonski M; Roch V; Marie PY; Karcher G; Imbert L; Verger A
Eur Radiol; 2023 Oct; 33(10):7089-7098. PubMed ID: 37148355
[TBL] [Abstract][Full Text] [Related]
5. Improved Detection of Transosseous Meningiomas Using
Kunz WG; Jungblut LM; Kazmierczak PM; Vettermann FJ; Bollenbacher A; Tonn JC; Schichor C; Rominger A; Albert NL; Bartenstein P; Reiser MF; Cyran CC
J Nucl Med; 2017 Oct; 58(10):1580-1587. PubMed ID: 28450556
[No Abstract] [Full Text] [Related]
6. The trends and significance of SSTR PET/CT added to MRI in follow-up imaging of low-grade meningioma treated with fractionated proton therapy.
Lütgendorf-Caucig C; Pelak M; Flechl B; Georg P; Fossati P; Stock M; Traub-Weidinger T; Marosi C; Haberler C; Zechmeister-Machhart G; Hermsmeyer L; Hug E; Staudenherz A
Strahlenther Onkol; 2023 Apr; 199(4):396-403. PubMed ID: 36260109
[TBL] [Abstract][Full Text] [Related]
7.
Kowalski ES; Khairnar R; Gryaznov AA; Kesari V; Koroulakis A; Raghavan P; Chen W; Woodworth G; Mishra M
Radiat Oncol; 2021 Aug; 16(1):151. PubMed ID: 34399805
[TBL] [Abstract][Full Text] [Related]
8. Clinical utility of somatostatin receptor positron emission tomography imaging biomarkers for characterization of meningioma among incidental central nervous system lesions.
Ensign SF; Agarwal M; Klanderman M; Badawy M; Halfdanarson TR; Johnson DR; Sonbol MB; Kendi AT
Nucl Med Commun; 2023 Jul; 44(7):663-670. PubMed ID: 37158225
[TBL] [Abstract][Full Text] [Related]
9. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
10. Differentiating dural metastases from meningioma: role of 68Ga DOTA-NOC PET/CT.
Purandare NC; Puranik A; Shah S; Agrawal A; Gupta T; Moiyadi A; Shetty P; Shridhar E; Patil V; Rangarajan V
Nucl Med Commun; 2020 Apr; 41(4):356-362. PubMed ID: 31939900
[TBL] [Abstract][Full Text] [Related]
11. Automated production of [
Lindner S; Simmet M; Gildehaus FJ; Jurkschat K; Wängler C; Wängler B; Bartenstein P; Schirrmacher R; Ilhan H
Nucl Med Biol; 2020; 88-89():86-95. PubMed ID: 32828007
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of [
Milosevic A; Styczen H; Grueneisen J; Li Y; Weber M; Fendler WP; Kirchner J; Damman P; Wrede K; Lazaridis L; Glas M; Guberina M; Eckstein A; Blau T; Herrmann K; Umutlu L; Forsting M; Deuschl C; Schaarschmidt B
J Nucl Med; 2023 Aug; 64(8):1185-1190. PubMed ID: 37385668
[TBL] [Abstract][Full Text] [Related]
13. Biodistribution and first clinical results of
Ilhan H; Lindner S; Todica A; Cyran CC; Tiling R; Auernhammer CJ; Spitzweg C; Boeck S; Unterrainer M; Gildehaus FJ; Böning G; Jurkschat K; Wängler C; Wängler B; Schirrmacher R; Bartenstein P
Eur J Nucl Med Mol Imaging; 2020 Apr; 47(4):870-880. PubMed ID: 31492994
[TBL] [Abstract][Full Text] [Related]
14. Comparison of somatostatin receptor expression in patients with neuroendocrine tumours with and without somatostatin analogue treatment imaged with [
Eschbach RS; Hofmann M; Späth L; Sheikh GT; Delker A; Lindner S; Jurkschat K; Wängler C; Wängler B; Schirrmacher R; Tiling R; Brendel M; Wenter V; Dekorsy FJ; Zacherl MJ; Todica A; Ilhan H; Grawe F; Cyran CC; Unterrainer M; Rübenthaler J; Knösel T; Paul T; Boeck S; Westphalen CB; Spitzweg C; Auernhammer CJ; Bartenstein P; Unterrainer LM; Beyer L
Front Oncol; 2023; 13():992316. PubMed ID: 36793617
[TBL] [Abstract][Full Text] [Related]
15. Somatostatin receptor subtype expression and radiomics from DWI-MRI represent SUV of [68Ga]Ga-DOTATOC PET in patients with meningioma.
Iglseder S; Iglseder A; Beliveau V; Heugenhauser J; Gizewski ER; Kerschbaumer J; Stockhammer G; Uprimny C; Virgolini I; Dudas J; Nevinny-Stickel M; Nowosielski M; Scherfler C
J Neurooncol; 2023 Sep; 164(3):711-720. PubMed ID: 37707754
[TBL] [Abstract][Full Text] [Related]
16. Detection of cranial meningiomas: comparison of ⁶⁸Ga-DOTATOC PET/CT and contrast-enhanced MRI.
Afshar-Oromieh A; Giesel FL; Linhart HG; Haberkorn U; Haufe S; Combs SE; Podlesek D; Eisenhut M; Kratochwil C
Eur J Nucl Med Mol Imaging; 2012 Sep; 39(9):1409-15. PubMed ID: 22669255
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of Brain Incidental Lesions Detected by
Albano D; Treglia G; Dondi F; Bertagna F
Medicina (Kaunas); 2022 Jul; 58(7):. PubMed ID: 35888635
[No Abstract] [Full Text] [Related]
18. PET imaging of somatostatin receptors using [68GA]DOTA-D-Phe1-Tyr3-octreotide: first results in patients with meningiomas.
Henze M; Schuhmacher J; Hipp P; Kowalski J; Becker DW; Doll J; Mäcke HR; Hofmann M; Debus J; Haberkorn U
J Nucl Med; 2001 Jul; 42(7):1053-6. PubMed ID: 11438627
[TBL] [Abstract][Full Text] [Related]
19. The usefulness of [
Wang P; Liu S; Li X; Liu X; Li S; Wu Z; Cheng X
Eur J Nucl Med Mol Imaging; 2023 Dec; 51(1):218-225. PubMed ID: 37682301
[TBL] [Abstract][Full Text] [Related]
20. Dosimetry and optimal scan time of [
Beyer L; Gosewisch A; Lindner S; Völter F; Mittlmeier LM; Tiling R; Brendel M; Cyran CC; Unterrainer M; Rübenthaler J; Auernhammer CJ; Spitzweg C; Böning G; Gildehaus FJ; Jurkschat K; Wängler C; Wängler B; Schirrmacher R; Wenter V; Todica A; Bartenstein P; Ilhan H
Eur J Nucl Med Mol Imaging; 2021 Oct; 48(11):3571-3581. PubMed ID: 33928401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
